2026 Annual Meeting | C108 - Research Career Symposium
| 01:00 PM - 01:05 PM CDT | Introduction |
Welcome
Peter B. Kang, MD, FAAN |
| 01:05 PM - 01:45 PM CDT | Speaker |
Translational Research: Navigating Bench to Bedside
Jin M. Lee, MD, PhD |
| 01:45 PM - 02:25 PM CDT | Speaker |
Balancing a Clinical Trial Portfolio
Alissa A. Thomas, MD, FAAN |
| 02:25 PM - 03:05 PM CDT | Speaker |
How to Use Big Data in a Neurology Research Career
Peter B. Kang, MD, FAAN |
| 03:05 PM - 03:25 PM CDT | Break |
break
|
| 03:25 PM - 04:05 PM CDT | Speaker |
Career Development Grants at NIH
Letitia Weigand, PhD |
| 04:05 PM - 04:45 PM CDT | Speaker |
Multiple Dimensions of NIH Engagement for Career Development
Nina F. Schor, MD, PhD, FAAN |
| 04:45 PM - 05:30 PM CDT | Discussion |
Discussion groups
|
| Peter B. Kang, MD, FAAN | Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurogene. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF Therapeutics (Italfarmaco). An immediate family member of Dr. Kang has received personal compensation in the range of $0-$499 for serving as a Consultant for Life Sciences Consultants. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MLAB Biosciences. Dr. Kang has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Kang has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Kang has received research support from Xtraordinary Joy Foundation. The institution of an immediate family member of Dr. Kang has received research support from Sarepta Therapeutics. The institution of Dr. Kang has received research support from Centers for Disease Control and Prevention (CDC). The institution of Dr. Kang has received research support from National Institutes of Health (NIH). The institution of Dr. Kang has received research support from Food and Drug Administration. The institution of Dr. Kang has received research support from National Initiative for Cockayne Syndrome. The institution of Dr. Kang has received research support from Greg Marzolf Jr Foundation. The institution of Dr. Kang has received research support from Sarepta Therapeutics. The institution of Dr. Kang has received research support from Duchenne UK - PPMD. The institution of an immediate family member of Dr. Kang has received research support from Regenerative Medicine MN. The institution of an immediate family member of Dr. Kang has received research support from Greg Marzolf Jr Foundation. The institution of an immediate family member of Dr. Kang has received research support from NIH. The institution of an immediate family member of Dr. Kang has received research support from Viljem Julijan Association for Children with Rare Disease. The institution of Dr. Kang has received research support from Minnesota Partnership. Dr. Kang has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Kang has received intellectual property interests from a discovery or technology relating to health care. Dr. Kang has received publishing royalties from a publication relating to health care. Dr. Kang has a non-compensated relationship as a Medical Advisory Board with Speak Foundation that is relevant to AAN interests or activities. Dr. Kang has a non-compensated relationship as a President (Including President-Elect and Past President) with Child Neurology Society that is relevant to AAN interests or activities. Dr. Kang has a non-compensated relationship as a Board Member with Child Neurology Foundation that is relevant to AAN interests or activities. |
| Alissa A. Thomas, MD, FAAN | The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals. |
| Jin M. Lee, MD, PhD | The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from Alnylam. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Council Member with NIH, NINDS. |
| Nina F. Schor, MD, PhD, FAAN | Dr. Schor has received publishing royalties from a publication relating to health care. Dr. Schor has received personal compensation in the range of $100,000-$499,999 for serving as a Deputy Director for Intramural Research with National Institutes of Health. |
| Letitia Weigand, PhD | Letitia Weigand, PhD has received personal compensation for serving as an employee of UCB. |